高盛：医疗诊断和临床实验室L领域竞争激烈,下调金域医学目标价及盈利预测,维持中立评级

水木调研纪 关注公众号：水木纪要 Goldman 高成 Sachs 可盗 27 May 2024 I 4:17PM CST China Healthcare: Diagnostics and Clinical Labs Intense competition in ICL: Cut Kingmed/Dian's TP/earnings, d/g Kingmed to Neutral; Buy AmoyDx 开报数据 We believe the headwinds ICLs are facing are more than short term pressure from Covid aftermath and may last longer than we had previously expected due to lower volumes, higher-than-expected competition and price cuts for diagnostic items. We now factor in intense competition and declining OPM, and ch ...